UniSuper Management’s Quest Diagnostics DGX Stock Holding History

UniSuper Management’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.16M	Sell	10,173 -2,713	-21%	-$532K	0.01%	413
2026 Q1	$2.53M	Sell	12,886 -945	-7%	-$184K	0.02%	412
2025 Q4	$2.4M	Sell	13,831 -2,740	-17%	-$499K	0.01%	439
2025 Q3	$3.16M	Buy	16,571 +2,576	+18%	+$457K	0.02%	387
2025 Q2	$2.51M	Sell	13,995 -200	-1%	-$34.7K	0.02%	418
2025 Q1	$2.4M	Sell	14,195 -493	-3%	-$81K	0.02%	413
2024 Q4	$2.22M	Buy	14,688 +2,069	+16%	+$322K	0.02%	426
2024 Q3	$1.96M	Buy	12,619 +833	+7%	+$124K	0.01%	450
2024 Q2	$1.61M	Buy	11,786 +3,256	+38%	+$446K	0.01%	459
2024 Q1	$1.14M	Sell	8,530 -40,940	-83%	-$5.31M	0.01%	468
2023 Q4	$6.82M	Sell	49,470 -411	-0.8%	-$54K	0.08%	162
2023 Q3	$6.08M	Sell	49,881 -173	-0.3%	-$23.1K	0.07%	160
2023 Q2	$7.04M	Buy	+50,054	New	+$6.9M	0.08%	156

Other funds holding DGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

UniSuper Management's DGX Position: Q2 2026 in Review

UniSuper Management reduced its Quest Diagnostics (DGX) stake by 21% in Q2 2026, selling an estimated $532K and leaving 10,173 shares worth $2.16M. The position accounts for 0.01% of the portfolio, ranked #413.

UniSuper Management first reported a position in DGX in Q2 2023 and has held it in 13 quarters since. The position peaked at $7.04M in Q2 2023. 1,105 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

UniSuper Management held 10,173 shares of Quest Diagnostics worth $2.16M as of Q2 2026.
UniSuper Management sold 2,713 Quest Diagnostics shares in Q2 2026, an estimated $532K.
Quest Diagnostics made up 0.01% of UniSuper Management's portfolio in Q2 2026, its #413 holding.
UniSuper Management first reported a position in Quest Diagnostics in Q2 2023 and has held it in 13 quarters since.
UniSuper Management's Quest Diagnostics position peaked at $7.04M in Q2 2023.
1,105 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on UniSuper Management's 13F filing for Q2 2026, filed 14 Aug 2026.